Literature DB >> 498503

Specific radioimmunoassay of ergot peptide alkaloids in plasma.

H F Schran, H J Schwarz, K C Talbot, L J Loeffler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498503

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.

Authors:  S W Sanders; N Haering; H Mosberg; H Jaeger
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Pharmacological actions of the main metabolites of dihydroergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Highly sensitive and specific radioimmunoassays for dihydroergotoxine components in plasma.

Authors:  F Collignon; P Pradelles
Journal:  Eur J Nucl Med       Date:  1984

4.  Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers.

Authors:  J J Ibraheem; L Paalzow; P Tfelt-Hansen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism.

Authors:  G Maurer; E Schreier; S Delaborde; R Nufer; A P Shukla
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

Review 6.  Ergot alkaloids--sources, structures and analytical methods.

Authors:  M Flieger; M Wurst; R Shelby
Journal:  Folia Microbiol (Praha)       Date:  1997       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.